or Try an Advanced Search...

    Technical Analysis for ARVN - Arvinas, Inc.

    Grade Last Price % Change Price Change
    F 33.14 2.79% 0.90
    ARVN closed up 2.79 percent on Friday, May 31, 2024, on 1.55 times normal volume.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Down
    Historical ARVN trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 0.00%
    Inside Day Range Contraction 0.00%
    Fell Below 20 DMA Bearish 2.79%
    200 DMA Support Bullish 2.79%
    Upper Bollinger Band Walk Strength -2.24%
    Gapped Down Weakness -2.24%
    50 DMA Resistance Bearish -5.99%
    Upper Bollinger Band Walk Strength -5.99%
    Outside Day Range Expansion -5.99%
    Gapped Up Strength -5.99%
    Older End-of-Day Signals for ARVN ...

       Recent Intraday Alerts

    Alert Time
    Possible Inside Day 1 day ago
    20 DMA Resistance 1 day ago
    Up 3% 1 day ago
    Rose Above 20 DMA 1 day ago
    Up 2% 1 day ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    ARVN Chart by TradingView
    Basic chart:

    Profile

    Arvinas Inc. is a biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Arvinas uses its proprietary technology platform to engineer proteolysis targeting chimeras, or PROTAC™ protein degraders, that are designed to harness the body’s own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Biology Disease Genetics Metabolism Chimera

    Is ARVN a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 23 Arvinas Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual Congress
    May 23 It Looks Like Arvinas, Inc.'s (NASDAQ:ARVN) CEO May Expect Their Salary To Be Put Under The Microscope
    May 16 Arvinas and Pfizer Announce Updated Clinical Data from Phase 1b Trial of Vepdegestrant in Combination with Palbociclib (IBRANCE®)
    May 11 Arvinas, Inc. (NASDAQ:ARVN) Just Reported First-Quarter Earnings And Analysts Are Lifting Their Estimates
    May 9 Arvinas Announces Upcoming Vepdegestrant Poster Presentations at the 2024 European Society for Medical Oncology (ESMO) Breast Cancer Annual Congress
    May 8 We Think Arvinas (NASDAQ:ARVN) Can Afford To Drive Business Growth
    May 7 Arvinas, Inc. (ARVN) Reports Q1 Loss, Lags Revenue Estimates
    May 7 Arvinas GAAP EPS of -$0.97 beats by $0.37, revenue of $25.3M misses by $6.76M
    May 7 Arvinas Reports First Quarter 2024 Financial Results and Provides Corporate Update
    May 2 Why Earnings Season Could Be Great for Arvinas (ARVN)
    See more ARVN news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 53.08
    52 Week Low 13.57
    Average Volume 648,406
    200-Day Moving Average 32.25
    50-Day Moving Average 35.15
    20-Day Moving Average 33.20
    10-Day Moving Average 34.15
    Average True Range 1.83
    RSI (14) 45.95
    ADX 19.18
    +DI 21.74
    -DI 20.75
    Chandelier Exit (Long, 3 ATRs) 31.89
    Chandelier Exit (Short, 3 ATRs) 36.73
    Upper Bollinger Bands 36.01
    Lower Bollinger Band 30.40
    Percent B (%b) 0.49
    BandWidth 16.92
    MACD Line -0.26
    MACD Signal Line -0.47
    MACD Histogram 0.2121
    Fundamentals Value
    Market Cap 1.82 Billion
    Num Shares 55 Million
    EPS -5.52
    Price-to-Earnings (P/E) Ratio -6.00
    Price-to-Sales 17.22
    Price-to-Book 6.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 35.05
    Resistance 3 (R3) 34.99 34.31 34.73
    Resistance 2 (R2) 34.31 33.82 34.33 34.62
    Resistance 1 (R1) 33.72 33.52 34.02 33.78 34.52
    Pivot Point 33.04 33.04 33.18 33.06 33.04
    Support 1 (S1) 32.45 32.55 32.75 32.51 31.76
    Support 2 (S2) 31.77 32.25 31.79 31.66
    Support 3 (S3) 31.18 31.77 31.55
    Support 4 (S4) 31.24